sars cov 2 — grants

Sort

8,912 grants matching “sars cov 2”

Development of pan-betacoronavirus vaccines

$709,989

Raiees Ahmad Andrabi · University Of Pennsylvania · R01 · FY2025 · AI

Evaluation of the Interplay between HIV and COVID-19 in a large urban safety-net HIV clinic

$709,784

Monica Gandhi · University Of California, San Francisco · R01 · FY2020 · AI

Engineering protease-resistant antiviral peptide inhibitors for SARS-CoV-2

$709,717

Anne Moscona · Columbia University Health Sciences · R01 · FY2025 · AI

Long-term Neuropsychiatric Sequelae of SARS-CoV-2 Infection in Late Life

$709,599

Amy Lynn Byers · Northern California Institute/Res/Edu · R01 · FY2025 · AG

Transcriptional Profiling to Discriminate Bacterial and Non-bacterial Respiratory Illnesses

$709,570

Ann R Falsey · University Of Rochester · R01 · FY2023 · AI

Leveraging Community-Academic Partnerships and Social Networks to Disseminate Vaccine-Related Information and Increase Vaccine Uptake Among Black Individuals with Rheumatic Diseases

$709,413

Rosalind Ramsey-Goldman · Northwestern University At Chicago · R01 · FY2024 · AR

mRNA-encoded Cas13 as a pan-respiratory antiviral

$709,376

Philip J Santangelo · Emory University · R01 · FY2024 · AI

Cognitive sequelae of cerebrovascular and gut dysfunction in post-acute COVID-19 syndrome.

$709,373

Andrei A Vakhtin · Lovelace Biomedical Research Institute · R01 · FY2024 · NS

Functional Role of HIF-PHDs in ARDS

$709,302

Holger K. Eltzschig · University Of Texas Hlth Sci Ctr Houston · R01 · FY2023 · HL

Family Dynamics, Fertility and Contraception, and Investments in Children across Generations

$709,020

Thomas Fraser Crossley · University Of Michigan At Ann Arbor · R01 · FY2025 · HD

The impact of prenatal maternal infection and inflammation on human brain development and psychopathology during adolescence

$708,989

Veerle Bergink · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · MH

Impact of the COVID-19 pandemic on patient outcomes, telehealth care delivery, and treatment for unhealthy alcohol use in vulnerable patients with advanced liver disease across two healthcare systems

$708,716

Mandana Khalili · University Of California, San Francisco · R01 · FY2021 · AA

Factors influencing TRM responses in upper airway tissue

$708,098

Pandurangan Vijayanand · La Jolla Institute For Immunology · U19 · FY2025 · AI

Computational modeling for HCV vaccine trial design and optimal vaccine-based combination interventions

$708,050

Harel Dahari · Loyola University Chicago · R01 · FY2023 · AI

Implementing Scalable, PAtient-centered Team-based Care for Adults with Type 2 Diabetes and Health Disparities (iPATH)

$708,002

Sara Jean Singer · Stanford University · R01 · FY2024 · MD

Impact of the COVID-19 pandemic on patient outcomes, telehealth care delivery, and treatment for unhealthy alcohol use in vulnerable patients with advanced liver disease across two healthcare systems

$707,715

Mandana Khalili · University Of California, San Francisco · R01 · FY2025 · AA

COVID-19 Lung Microvascular and Parenchymal Sequelae (Lung-MaPS)

$707,532

Elizabeth Oelsner · Columbia University Health Sciences · R01 · FY2022 · HL

Determinants of Convalescent and Vaccine-induced Mucosal Specific Immunity to SARS-CoV-2 and Variants of Concern in Children with Asthma

$707,188

William Gerald Teague · University Of Virginia · R01 · FY2023 · AI

Longitudinal study of health outcomes and mitigating factors in the aftermath of the COVID pandemic

$706,889

Manoj Mohanan · Duke University · R01 · FY2021 · HD

Early life B cell responses and inflammation following SARS-CoV-2 infection

$706,463

Genevieve Giny Fouda Amou Ou · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · AI

Natural Killer cells and the Immunogenetics of COVID-19

$706,411

Paul John Norman · University Of Colorado Denver · R01 · FY2024 · AI

Development of pan-betacoronavirus vaccines

Evaluation of the Interplay between HIV and COVID-19 in a large urban safety-net HIV clinic

Engineering protease-resistant antiviral peptide inhibitors for SARS-CoV-2

Long-term Neuropsychiatric Sequelae of SARS-CoV-2 Infection in Late Life

Transcriptional Profiling to Discriminate Bacterial and Non-bacterial Respiratory Illnesses

Leveraging Community-Academic Partnerships and Social Networks to Disseminate Vaccine-Related Information and Increase Vaccine Uptake Among Black Individuals with Rheumatic Diseases

mRNA-encoded Cas13 as a pan-respiratory antiviral

Cognitive sequelae of cerebrovascular and gut dysfunction in post-acute COVID-19 syndrome.

Functional Role of HIF-PHDs in ARDS

Family Dynamics, Fertility and Contraception, and Investments in Children across Generations

The impact of prenatal maternal infection and inflammation on human brain development and psychopathology during adolescence

Alaska Native Communities Advancing Vaccine Uptake

ClinEX - Clinical Evidence Extraction, Representation, and Appraisal

Mechanisms of protective memory CD8 T-cell induction by mRNA-LNP vaccines

Mechanisms of protective memory CD8 T-cell induction by mRNA-LNP vaccines

Impact of the COVID-19 pandemic on patient outcomes, telehealth care delivery, and treatment for unhealthy alcohol use in vulnerable patients with advanced liver disease across two healthcare systems

Factors influencing TRM responses in upper airway tissue

Computational modeling for HCV vaccine trial design and optimal vaccine-based combination interventions

Implementing Scalable, PAtient-centered Team-based Care for Adults with Type 2 Diabetes and Health Disparities (iPATH)

Impact of the COVID-19 pandemic on patient outcomes, telehealth care delivery, and treatment for unhealthy alcohol use in vulnerable patients with advanced liver disease across two healthcare systems

COVID-19 Lung Microvascular and Parenchymal Sequelae (Lung-MaPS)

Determinants of Convalescent and Vaccine-induced Mucosal Specific Immunity to SARS-CoV-2 and Variants of Concern in Children with Asthma

Longitudinal study of health outcomes and mitigating factors in the aftermath of the COVID pandemic

Early life B cell responses and inflammation following SARS-CoV-2 infection

Natural Killer cells and the Immunogenetics of COVID-19